Data released by the U.S. Centers for Disease Control and Prevention show new Covid-19 infections are concentrated largely among unvaccinated people. . . . → Read More: Infographic – Unvaccinated Driving New Covid-19 Cases
|
|||||
Data released by the U.S. Centers for Disease Control and Prevention show new Covid-19 infections are concentrated largely among unvaccinated people. . . . → Read More: Infographic – Unvaccinated Driving New Covid-19 Cases The Food and Drug Administration stopped a company’s clinical trials of off-the-shelf engineered T-cells after a patient showed an abnormal chromosomal reaction. . . . → Read More: FDA Halts Off-the-Shelf T-Cell Cancer Trials A company developing a one-time treatment for HIV infections using the gene-editing technique Crispr says it received FDA clearance to begin a clinical trial. . . . → Read More: FDA Okays One-Time HIV Treatment Clinical Trial A new poll shows a jump in the percentage of American workers now required by employers to get vaccinated against Covid-19. . . . → Read More: Infographic – US Employer Vaccine Mandates Tick Up The Food and Drug Administration released yesterday a warning letter sent in late August to a company conducting clinical trials of a food therapy for Covid-19 symptoms. . . . → Read More: FDA Sends Warning on Covid-19 Food Therapy Trials The Food and Drug Administration has authorized a clinical trial of stem cells extracted and cultured from patients to treat their cases of multiple sclerosis. . . . → Read More: FDA Clears Stem Cell Trial for Multiple Sclerosis A tiny remote-controlled device that carries chemotherapy drugs to brain tumors received orphan drug status from the Food and Drug Administration. . . . → Read More: Micro Brain Robot Granted Orphan Status An organization studying stem cell therapies says it received FDA authorization for a clinical trial to test donated stem cells to treat Parkinson’s disease. . . . → Read More: FDA Okays Trial of Donated Stem Cells for Parkinson’s The Food and Drug Administration updated its emergency authorization for a dual-antibody Covid-19 therapy to allow for a lower and injectable dose. . . . → Read More: FDA Okays Lower Dose, Injected Covid-19 Antibodies Results from a large-scale clinical trial show almost the same health outcomes for patients prescribed high or low doses of aspirin to prevent heart disease. . . . → Read More: Trial Shows Same High/Low Dose Aspirin Outcomes |
|||||
Copyright © 2024 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |